Role of salt bridge dynamics in inter domain recognition of human impdh isoforms

An insight to inhibitor topology for isoform-ii

Hridoy R. Bairagya, Bishnu P. Mukhopadhyay, Asim K Bera

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Inosine monophosphate dehydrogenase (IMPDH) enzyme involves in the biosynthesis pathway of guanosine nucleotide. Type II isoform of the enzyme is selectively upregulated in neoplastic fast replicating lymphocytes and CML cancer cells. The hIMPDH-II is an excellent target for antileukemic agent. The detailed investigation during MD-Simulation (15 ns) of three different unliganded structures (1B3O, 1JCN and 1JR1) have clearly explored the salt bridge mediated stabilization of inter or intra domain (catalytic domains IN, with res. Id. 28–111 and 233–504, whereas two CBS domains C1, C2 are 112–171 and 172–232) in IMPDH enzyme which are mostly inaccessible in their X-rays structures. The salt bridge interaction in IN—C1 inter-domain of hIMPDH-I, IN—C2 of IMPDH-II and C1—IC of nhIMPDH-II are discriminative features among the isoforms. The IN—C2 recognition in hIMPDH-II (1B3O) is missing in type-I isoform (1JCN). The salt bridge interaction D232—K238 at the surface of protein and the involvement of three conserved water molecules or the hydrophilic centers (WA232 OD1, WB232 OD2 and W238 NZ) to those acidic and basic residues seem to be unique in hIMPDH-II. The hydrophilic susceptibility, geometrical and electronic consequences of this salt bridge interaction could be useful to design the topology of specific inhibitor for hIMPDH-II which may not be effective for hIMPDH-I. Possibly, the aliphatic ligand containing carboxyl, amide or hydrophilic groups with flexible structure may be implicated for hIMPDH-II inhibitor design using the conserved water mimic drug design protocol.

Original languageEnglish (US)
Pages (from-to)441-462
Number of pages22
JournalJournal of Biomolecular Structure and Dynamics
Volume29
Issue number3
DOIs
StatePublished - Jan 1 2011

Fingerprint

Inosine Monophosphate
Protein Isoforms
Salts
Oxidoreductases
Enzymes
Water
Guanosine
Drug Design
Amides
Catalytic Domain
Membrane Proteins
Nucleotides
X-Rays
Lymphocytes
Ligands
Neoplasms

Keywords

  • Dynamics of salt bridges
  • IMPDH isoforms
  • Inhibitor topology
  • Inter and intra domain recognition

Cite this

Role of salt bridge dynamics in inter domain recognition of human impdh isoforms : An insight to inhibitor topology for isoform-ii. / Bairagya, Hridoy R.; Mukhopadhyay, Bishnu P.; Bera, Asim K.

In: Journal of Biomolecular Structure and Dynamics, Vol. 29, No. 3, 01.01.2011, p. 441-462.

Research output: Contribution to journalArticle

@article{edf6486ee2dc44e6a2bbd9a3dff3ea6a,
title = "Role of salt bridge dynamics in inter domain recognition of human impdh isoforms: An insight to inhibitor topology for isoform-ii",
abstract = "Inosine monophosphate dehydrogenase (IMPDH) enzyme involves in the biosynthesis pathway of guanosine nucleotide. Type II isoform of the enzyme is selectively upregulated in neoplastic fast replicating lymphocytes and CML cancer cells. The hIMPDH-II is an excellent target for antileukemic agent. The detailed investigation during MD-Simulation (15 ns) of three different unliganded structures (1B3O, 1JCN and 1JR1) have clearly explored the salt bridge mediated stabilization of inter or intra domain (catalytic domains IN, with res. Id. 28–111 and 233–504, whereas two CBS domains C1, C2 are 112–171 and 172–232) in IMPDH enzyme which are mostly inaccessible in their X-rays structures. The salt bridge interaction in IN—C1 inter-domain of hIMPDH-I, IN—C2 of IMPDH-II and C1—IC of nhIMPDH-II are discriminative features among the isoforms. The IN—C2 recognition in hIMPDH-II (1B3O) is missing in type-I isoform (1JCN). The salt bridge interaction D232—K238 at the surface of protein and the involvement of three conserved water molecules or the hydrophilic centers (WA232 OD1, WB232 OD2 and W238 NZ) to those acidic and basic residues seem to be unique in hIMPDH-II. The hydrophilic susceptibility, geometrical and electronic consequences of this salt bridge interaction could be useful to design the topology of specific inhibitor for hIMPDH-II which may not be effective for hIMPDH-I. Possibly, the aliphatic ligand containing carboxyl, amide or hydrophilic groups with flexible structure may be implicated for hIMPDH-II inhibitor design using the conserved water mimic drug design protocol.",
keywords = "Dynamics of salt bridges, IMPDH isoforms, Inhibitor topology, Inter and intra domain recognition",
author = "Bairagya, {Hridoy R.} and Mukhopadhyay, {Bishnu P.} and Bera, {Asim K}",
year = "2011",
month = "1",
day = "1",
doi = "10.1080/07391102.2011.10507397",
language = "English (US)",
volume = "29",
pages = "441--462",
journal = "Journal of Biomolecular Structure and Dynamics",
issn = "0739-1102",
publisher = "Adenine Press",
number = "3",

}

TY - JOUR

T1 - Role of salt bridge dynamics in inter domain recognition of human impdh isoforms

T2 - An insight to inhibitor topology for isoform-ii

AU - Bairagya, Hridoy R.

AU - Mukhopadhyay, Bishnu P.

AU - Bera, Asim K

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Inosine monophosphate dehydrogenase (IMPDH) enzyme involves in the biosynthesis pathway of guanosine nucleotide. Type II isoform of the enzyme is selectively upregulated in neoplastic fast replicating lymphocytes and CML cancer cells. The hIMPDH-II is an excellent target for antileukemic agent. The detailed investigation during MD-Simulation (15 ns) of three different unliganded structures (1B3O, 1JCN and 1JR1) have clearly explored the salt bridge mediated stabilization of inter or intra domain (catalytic domains IN, with res. Id. 28–111 and 233–504, whereas two CBS domains C1, C2 are 112–171 and 172–232) in IMPDH enzyme which are mostly inaccessible in their X-rays structures. The salt bridge interaction in IN—C1 inter-domain of hIMPDH-I, IN—C2 of IMPDH-II and C1—IC of nhIMPDH-II are discriminative features among the isoforms. The IN—C2 recognition in hIMPDH-II (1B3O) is missing in type-I isoform (1JCN). The salt bridge interaction D232—K238 at the surface of protein and the involvement of three conserved water molecules or the hydrophilic centers (WA232 OD1, WB232 OD2 and W238 NZ) to those acidic and basic residues seem to be unique in hIMPDH-II. The hydrophilic susceptibility, geometrical and electronic consequences of this salt bridge interaction could be useful to design the topology of specific inhibitor for hIMPDH-II which may not be effective for hIMPDH-I. Possibly, the aliphatic ligand containing carboxyl, amide or hydrophilic groups with flexible structure may be implicated for hIMPDH-II inhibitor design using the conserved water mimic drug design protocol.

AB - Inosine monophosphate dehydrogenase (IMPDH) enzyme involves in the biosynthesis pathway of guanosine nucleotide. Type II isoform of the enzyme is selectively upregulated in neoplastic fast replicating lymphocytes and CML cancer cells. The hIMPDH-II is an excellent target for antileukemic agent. The detailed investigation during MD-Simulation (15 ns) of three different unliganded structures (1B3O, 1JCN and 1JR1) have clearly explored the salt bridge mediated stabilization of inter or intra domain (catalytic domains IN, with res. Id. 28–111 and 233–504, whereas two CBS domains C1, C2 are 112–171 and 172–232) in IMPDH enzyme which are mostly inaccessible in their X-rays structures. The salt bridge interaction in IN—C1 inter-domain of hIMPDH-I, IN—C2 of IMPDH-II and C1—IC of nhIMPDH-II are discriminative features among the isoforms. The IN—C2 recognition in hIMPDH-II (1B3O) is missing in type-I isoform (1JCN). The salt bridge interaction D232—K238 at the surface of protein and the involvement of three conserved water molecules or the hydrophilic centers (WA232 OD1, WB232 OD2 and W238 NZ) to those acidic and basic residues seem to be unique in hIMPDH-II. The hydrophilic susceptibility, geometrical and electronic consequences of this salt bridge interaction could be useful to design the topology of specific inhibitor for hIMPDH-II which may not be effective for hIMPDH-I. Possibly, the aliphatic ligand containing carboxyl, amide or hydrophilic groups with flexible structure may be implicated for hIMPDH-II inhibitor design using the conserved water mimic drug design protocol.

KW - Dynamics of salt bridges

KW - IMPDH isoforms

KW - Inhibitor topology

KW - Inter and intra domain recognition

UR - http://www.scopus.com/inward/record.url?scp=81555210942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81555210942&partnerID=8YFLogxK

U2 - 10.1080/07391102.2011.10507397

DO - 10.1080/07391102.2011.10507397

M3 - Article

VL - 29

SP - 441

EP - 462

JO - Journal of Biomolecular Structure and Dynamics

JF - Journal of Biomolecular Structure and Dynamics

SN - 0739-1102

IS - 3

ER -